|
Market Cap | 2.41B | EPS (ttm) | -0.11 |
P/E | - | EPS this Y | 200.87% |
Forward P/E | 27.63 | EPS next Y | 267.30% |
PEG | - | EPS past 5Y | - |
P/S | 2.77 | EPS next 5Y | - |
P/B | 6.99 | EPS Q/Q | 110.59% |
Dividend | - | Sales Q/Q | 47.50% |
Insider Own | 34.85% | Inst Own | 38.55% |
Insider Trans | -3.91% | Inst Trans | 4.54% |
Short Float | 12.51% | Earnings | May 06/a |
Analyst Recom | 1.92 | Target Price | 16.02 |
Avg Volume | 5.27M | 52W Range | 5.65 - 17.16 |
|
|
|
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Baird Melissa | Chief Operating Officer | May 03 '24 | Option Exercise | 0.40 | 11,750 | 4,700 | 550,682 | May 03 06:38 PM | Baird Melissa | Chief Operating Officer | May 03 '24 | Sale | 11.64 | 11,750 | 136,826 | 538,932 | May 03 06:38 PM | Baird Melissa | Chief Operating Officer | May 02 '24 | Option Exercise | 0.40 | 11,750 | 4,700 | 550,682 | May 03 06:38 PM | Baird Melissa | Chief Operating Officer | May 02 '24 | Sale | 12.08 | 11,750 | 141,923 | 538,932 | May 03 06:38 PM | Dudum Andrew | Chief Executive Officer | May 01 '24 | Option Exercise | 2.43 | 188,888 | 458,998 | 188,888 | May 03 06:38 PM |
|
|
|
|
Market Cap | 42.71M | EPS (ttm) | -18.25 |
P/E | - | EPS this Y | 41.06% |
Forward P/E | - | EPS next Y | 41.09% |
PEG | - | EPS past 5Y | 7.97% |
P/S | 0.88 | EPS next 5Y | - |
P/B | 2.32 | EPS Q/Q | 47.27% |
Dividend | - | Sales Q/Q | -33.59% |
Insider Own | 11.14% | Inst Own | 65.43% |
Insider Trans | -43.75% | Inst Trans | -66.79% |
Short Float | 9.69% | Earnings | Mar 27/b |
Analyst Recom | 1.33 | Target Price | 33.00 |
Avg Volume | 131.65K | 52W Range | 8.25 - 27.02 |
|
|
|
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Amoroso Michael | President and CEO | May 02 '24 | Sale | 10.32 | 1,526 | 15,748 | 13,772 | May 03 06:29 PM | List Alan | Chief Medical Officer | May 02 '24 | Sale | 10.32 | 290 | 2,993 | 4,488 | May 03 06:30 PM | Scimeca Dario | General Counsel and Secretary | May 02 '24 | Sale | 10.32 | 272 | 2,807 | 5,680 | May 03 06:33 PM | SMITH J. JEFFERSON | Chief Research Officer | May 02 '24 | Sale | 10.32 | 154 | 1,589 | 67,613 | May 03 06:32 PM | List Alan | Chief Medical Officer | Apr 30 '24 | Sale | 10.03 | 238 | 2,386 | 3,796 | Apr 30 06:34 PM |
|
|
|
|
Market Cap | 187.89M | EPS (ttm) | 0.43 |
P/E | 7.54 | EPS this Y | -48.00% |
Forward P/E | 10.80 | EPS next Y | 15.38% |
PEG | 0.50 | EPS past 5Y | - |
P/S | 0.36 | EPS next 5Y | 15.00% |
P/B | 1.26 | EPS Q/Q | -33.23% |
Dividend | - | Sales Q/Q | -4.68% |
Insider Own | 12.16% | Inst Own | 82.69% |
Insider Trans | -4.15% | Inst Trans | 8.28% |
Short Float | 8.78% | Earnings | Mar 21/b |
Analyst Recom | 2.00 | Target Price | 5.25 |
Avg Volume | 268.48K | 52W Range | 3.12 - 5.36 |
|
|
|
Destination XL Group, Inc. is engaged in the retail of specialty products. It offers shirts, pants, shorts, outerwear, activewear, suiting, underwear and lounge, shoes, and accessories. It distributes its products under the following brand names: Destination X, DXL, DXL Men's Apparel, DXL Outlets, Casual Male XL, and Casual Male XL Outlets. It operates through the Stores, and Direct Businesses segments. The company was founded by Calvin Margolis and Stanley I. Berger in 1976 and is headquartered in Canton, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fund 1 Investments, LLC | 10% Owner | May 03 '24 | Sale | 3.15 | 225,000 | 708,795 | 5,691,577 | May 03 06:32 PM | REATH JAMES | Chief Marketing Officer | Apr 01 '24 | Option Exercise | 0.00 | 2,583 | 0 | 13,463 | Apr 10 04:25 PM | Stratton Peter H Jr. | EVP, CFO, Treasurer | Apr 01 '24 | Option Exercise | 0.00 | 4,560 | 0 | 231,948 | Apr 10 04:25 PM | Molloy Robert S | General Counsel & Secretary | Feb 15 '24 | Option Exercise | 0.53 | 20,000 | 10,600 | 260,409 | Feb 16 04:30 PM | Molloy Robert S | General Counsel & Secretary | Feb 15 '24 | Sale | 4.00 | 20,000 | 80,006 | 240,409 | Feb 16 04:30 PM |
|
|
| |
|
Market Cap | 1.82B | EPS (ttm) | -1.57 |
P/E | - | EPS this Y | -8.84% |
Forward P/E | - | EPS next Y | -19.06% |
PEG | - | EPS past 5Y | -68.02% |
P/S | - | EPS next 5Y | - |
P/B | 4.31 | EPS Q/Q | -51.60% |
Dividend | - | Sales Q/Q | - |
Insider Own | 32.59% | Inst Own | 64.22% |
Insider Trans | 1.99% | Inst Trans | 17.24% |
Short Float | 9.15% | Earnings | Feb 22/b |
Analyst Recom | 1.00 | Target Price | 32.60 |
Avg Volume | 736.60K | 52W Range | 5.12 - 20.90 |
|
|
|
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Donovan Joanne M. | CMO | May 02 '24 | Sale | 18.91 | 3,682 | 69,627 | 19,897 | May 03 06:27 PM | KOCH KEVIN | President and CEO | May 02 '24 | Sale | 18.91 | 3,152 | 59,604 | 14,478 | May 03 06:26 PM | Carruthers R Michael | Chief Financial Officer | May 02 '24 | Sale | 18.91 | 2,157 | 40,789 | 35,230 | May 03 06:30 PM | MOORE JOHN R | General Counsel | May 02 '24 | Sale | 18.91 | 1,956 | 36,988 | 3,252 | May 03 06:31 PM | Derakhshan Behrad | Chief Business Officer | May 02 '24 | Sale | 18.91 | 1,718 | 32,487 | 13,422 | May 03 06:29 PM |
|
|
|
|
Market Cap | 19.01B | EPS (ttm) | 2.05 |
P/E | 30.10 | EPS this Y | -5.51% |
Forward P/E | 12.28 | EPS next Y | 2.23% |
PEG | 20.07 | EPS past 5Y | - |
P/S | 4.20 | EPS next 5Y | 1.50% |
P/B | 2.37 | EPS Q/Q | 368.46% |
Dividend | - | Sales Q/Q | 2.56% |
Insider Own | 24.23% | Inst Own | 56.54% |
Insider Trans | -0.35% | Inst Trans | -0.54% |
Short Float | 5.48% | Earnings | Feb 26/a |
Analyst Recom | 2.63 | Target Price | 78.03 |
Avg Volume | 3.49M | 52W Range | 58.87 - 75.90 |
|
|
|
Zoom Video Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Steckelberg Kelly | Chief Financial Officer | May 01 '24 | Sale | 61.42 | 5,007 | 307,519 | 0 | May 03 06:28 PM | Bawa Aparna | Chief Operating Officer | Apr 18 '24 | Sale | 60.18 | 21,968 | 1,322,027 | 1,978 | Apr 22 06:40 PM | Steckelberg Kelly | Chief Financial Officer | Apr 17 '24 | Sale | 59.36 | 5,007 | 297,203 | 0 | Apr 19 06:19 PM | Yuan Eric S. | Chief Executive Officer | Apr 11 '24 | Sale | 62.45 | 2,420 | 151,123 | 92,720 | Apr 12 06:13 PM | Yuan Eric S. | Chief Executive Officer | Apr 10 '24 | Sale | 61.98 | 27,963 | 1,733,129 | 95,140 | Apr 12 06:13 PM |
|
|
| |
|
Market Cap | 2.10B | EPS (ttm) | -1.55 |
P/E | - | EPS this Y | -9.14% |
Forward P/E | - | EPS next Y | -7.82% |
PEG | - | EPS past 5Y | -43.41% |
P/S | 47.10 | EPS next 5Y | 12.00% |
P/B | 4.46 | EPS Q/Q | -28.81% |
Dividend | - | Sales Q/Q | -20.36% |
Insider Own | 31.78% | Inst Own | 71.84% |
Insider Trans | -1.51% | Inst Trans | 4.55% |
Short Float | 23.89% | Earnings | May 09/a |
Analyst Recom | 2.43 | Target Price | 13.00 |
Avg Volume | 6.39M | 52W Range | 4.55 - 16.75 |
|
|
|
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gibson Christopher | Chief Executive Officer | May 02 '24 | Sale | 8.47 | 50,000 | 423,500 | 834,820 | May 03 06:24 PM | Gibson Christopher | Chief Executive Officer | May 01 '24 | Sale | 7.73 | 50,000 | 386,500 | 863,524 | May 03 06:24 PM | Borgeson Blake | Director | Apr 30 '24 | Sale | 7.95 | 11,447 | 90,964 | 7,218,414 | May 02 05:41 PM | Marriott Tina | President and COO | Apr 25 '24 | Option Exercise | 1.06 | 3,000 | 3,180 | 546,231 | Apr 29 06:41 PM | Marriott Tina | President and COO | Apr 25 '24 | Sale | 7.67 | 3,000 | 23,020 | 543,231 | Apr 29 06:41 PM |
|
|
|
|
Market Cap | 17.62B | EPS (ttm) | 12.03 |
P/E | 10.28 | EPS this Y | -33.77% |
Forward P/E | 19.90 | EPS next Y | 1.96% |
PEG | - | EPS past 5Y | 84.46% |
P/S | 4.08 | EPS next 5Y | -3.30% |
P/B | 42.45 | EPS Q/Q | 812.62% |
Dividend | - | Sales Q/Q | 7.34% |
Insider Own | 0.73% | Inst Own | 91.45% |
Insider Trans | -19.64% | Inst Trans | -1.86% |
Short Float | 1.78% | Earnings | May 02/a |
Analyst Recom | 1.84 | Target Price | 140.02 |
Avg Volume | 1.45M | 52W Range | 67.43 - 127.15 |
|
|
|
GoDaddy, Inc. engages in the provision of simple and easy-to-use products on a single technology platform wrapped with personalized guidance. It operates under the Applications and Commerce (A and C) and Core Platform (Core) segments. The A and C segment includes selling products containing proprietary software, commerce products, third-party email, productivity solutions, and certain products included in bundled offerings of proprietary software products. The Core segment includes domain registrations and renewals, aftermarket domain sales, website hosting products, website security products not included in bundled offerings of proprietary software, and products that do not contain a software component. The company was founded by Robert R. Parsons in 1997 and is headquartered in Tempe, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Chen Roger | Chief Operating Officer | May 01 '24 | Sale | 122.60 | 4,000 | 490,400 | 200,632 | May 03 06:23 PM | McCaffrey Mark | Chief Financial Officer | Apr 02 '24 | Sale | 120.83 | 624 | 75,401 | 116,328 | Apr 03 09:18 PM | Chen Roger | Chief Operating Officer | Apr 01 '24 | Sale | 118.56 | 4,000 | 474,240 | 204,632 | Apr 03 09:18 PM | Bhutani Amanpal Singh | Chief Executive Officer | Mar 21 '24 | Sale | 120.00 | 2,500 | 300,000 | 384,323 | Mar 25 06:27 PM | Bhutani Amanpal Singh | Chief Executive Officer | Mar 08 '24 | Sale | 113.80 | 7,600 | 864,880 | 386,823 | Mar 11 07:13 PM |
|
|
| |
|
Market Cap | 52.08B | EPS (ttm) | 0.09 |
P/E | 258.36 | EPS this Y | 32.08% |
Forward P/E | 58.73 | EPS next Y | 20.29% |
PEG | - | EPS past 5Y | - |
P/S | 23.41 | EPS next 5Y | - |
P/B | 14.77 | EPS Q/Q | 182.86% |
Dividend | - | Sales Q/Q | 19.61% |
Insider Own | 15.27% | Inst Own | 39.49% |
Insider Trans | -4.02% | Inst Trans | 4.18% |
Short Float | 4.12% | Earnings | May 06/a |
Analyst Recom | 3.20 | Target Price | 20.43 |
Avg Volume | 68.19M | 52W Range | 7.28 - 27.50 |
|
|
|
Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates under the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Moore Alexander D. | Director | May 01 '24 | Sale | 22.02 | 20,000 | 440,306 | 1,595,519 | May 03 06:16 PM | Palantir Technologies Inc. | Former 10% Owner | Apr 24 '24 | Sale | 0.37 | 18,621 | 6,972 | 5,233,625 | Apr 24 08:25 PM | Palantir Technologies Inc. | Former 10% Owner | Apr 23 '24 | Sale | 0.37 | 18,471 | 6,792 | 5,252,246 | Apr 24 08:25 PM | Palantir Technologies Inc. | Former 10% Owner | Apr 22 '24 | Sale | 0.34 | 3,200 | 1,089 | 5,270,717 | Apr 24 08:25 PM | Palantir Technologies Inc. | 10% Owner | Apr 19 '24 | Sale | 0.34 | 12,086 | 4,143 | 5,273,917 | Apr 19 09:09 PM |
|
|
|
|
Market Cap | 5.11B | EPS (ttm) | 6.10 |
P/E | 16.57 | EPS this Y | -23.64% |
Forward P/E | 14.71 | EPS next Y | 15.31% |
PEG | 2.27 | EPS past 5Y | 19.89% |
P/S | 1.04 | EPS next 5Y | 7.30% |
P/B | 35.77 | EPS Q/Q | -18.28% |
Dividend | 0.25% | Sales Q/Q | 1.44% |
Insider Own | 2.72% | Inst Own | 96.96% |
Insider Trans | -4.99% | Inst Trans | -0.24% |
Short Float | 2.40% | Earnings | Apr 26/b |
Analyst Recom | 2.00 | Target Price | 124.00 |
Avg Volume | 255.13K | 52W Range | 87.20 - 134.67 |
|
|
|
TriNet Group, Inc. engages in the provision of comprehensive human resources solutions for small and medium-size businesses. The firm also offers access to human capital expertise, benefits, risk mitigation, compliance, payroll, and research and development tax credit services. The company was founded by Martin Babinec in 1988 and is headquartered in Dublin, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Chamberlain Paul Edward | Director | May 01 '24 | Sale | 101.02 | 375 | 37,882 | 36,341 | May 03 06:12 PM | Goldfield Burton M. | Director | Feb 22 '24 | Sale | 124.63 | 16,200 | 2,018,956 | 364,479 | Feb 26 06:26 PM | WELLINGTON SAMANTHA | EVP, CLO and SECRETARY | Feb 22 '24 | Sale | 124.88 | 14,271 | 1,782,231 | 48,562 | Feb 26 06:27 PM | LOWELL WAYNE B | Director | Feb 21 '24 | Sale | 122.22 | 10,000 | 1,222,230 | 84,766 | Feb 23 04:34 PM | TUMINELLI KELLY L | EVP & CHIEF FINANCIAL OFFICER | Feb 21 '24 | Sale | 122.67 | 4,396 | 539,235 | 65,999 | Feb 23 06:08 PM |
|
|
|
|
Market Cap | 76.64B | EPS (ttm) | 3.84 |
P/E | 73.38 | EPS this Y | 15.18% |
Forward P/E | 40.44 | EPS next Y | 17.42% |
PEG | 4.13 | EPS past 5Y | 25.42% |
P/S | 18.80 | EPS next 5Y | 17.75% |
P/B | 21.48 | EPS Q/Q | 2.27% |
Dividend | - | Sales Q/Q | -1.23% |
Insider Own | 0.88% | Inst Own | 89.07% |
Insider Trans | -12.98% | Inst Trans | 0.95% |
Short Float | 0.91% | Earnings | Apr 22/a |
Analyst Recom | 1.83 | Target Price | 325.87 |
Avg Volume | 1.61M | 52W Range | 198.92 - 327.36 |
|
|
|
Cadence Design Systems, Inc. engages in the design and development of integrated circuits and electronic devices. The company was founded by Alberto Sangiovanni-Vincentelli, Gudmundur A. Hjartarson, K. Bobby Chao, and K. Charles Janac in June 1988 and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cunningham Paul | Sr. Vice President | May 01 '24 | Sale | 275.36 | 1,000 | 275,360 | 67,144 | May 03 06:03 PM | Nisewaner Karna | SVP & General Counsel | May 01 '24 | Sale | 275.36 | 600 | 165,216 | 20,480 | May 03 06:04 PM | SANGIOVANNI VINCENTELLI ALBERT | Director | Apr 15 '24 | Sale | 308.83 | 1,500 | 463,238 | 50,183 | Apr 17 05:21 PM | Cunningham Paul | Sr. Vice President | Apr 01 '24 | Sale | 310.46 | 1,000 | 310,460 | 68,144 | Apr 03 05:25 PM | Nisewaner Karna | SVP & General Counsel | Apr 01 '24 | Sale | 310.46 | 600 | 186,276 | 21,080 | Apr 03 05:20 PM |
|
|
|